In this Healio Video Perspective, Arshad M. Khanani, MD, MA, FASRS, speaks about the positive real-world outcomes of faricimab in the TRUCKEE and TAHOE studies, presented at the Euretina congress in Amsterdam.
TRUCKEE in neovascular age-related macular degeneration and TAHOE in diabetic macular edema are independent studies carried out in the U.S. and included both naive and switch patients, with no exclusion criteria. Vabysmo (faricimab, Genentech) showed rapid and stable improvement in all anatomic parameters, with no new safety signals. In a subset of patients, the Notal OCT Analyzer was